Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ImmunoPrecise Antibodies Ltd. - Common Stock
(NQ:
IPA
)
2.070
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ImmunoPrecise Antibodies Ltd. - Common Stock
< Previous
1
2
3
4
Next >
Earnings Scheduled For March 14, 2024
↗
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Earnings Outlook For ImmunoPrecise Antibodies
↗
March 13, 2024
Via
Benzinga
Earnings Preview For ImmunoPrecise Antibodies
↗
December 13, 2023
Via
Benzinga
Earnings Outlook For ImmunoPrecise Antibodies
↗
September 13, 2023
Via
Benzinga
ImmunoPrecise Antibodies's Earnings Outlook
↗
July 06, 2023
Via
Benzinga
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
↗
February 12, 2024
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words...
Via
Benzinga
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
↗
January 09, 2024
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently
Via
Benzinga
Earnings Outlook For ImmunoPrecise Antibodies
↗
March 15, 2023
Via
Benzinga
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024
↗
December 14, 2023
IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For December 14, 2023
↗
December 14, 2023
Companies Reporting Before The Bell • Live Ventures (NASDAQ:LIVE) is estimated to report earnings for its fourth quarter. • Jabil (NYSE:JBL) is projected to report earnings for its first quarter.
Via
Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
↗
December 06, 2023
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via
Benzinga
Topics
Stocks
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
December 06, 2023
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.
Via
Benzinga
Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Today
↗
December 06, 2023
ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at
Via
Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
↗
December 06, 2023
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...
Via
Benzinga
Topics
Stocks
US Stocks Higher; Private Payrolls Rise By 103,000 In November
↗
December 06, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...
Via
Benzinga
Topics
Stocks
Why Is Carbon Revolution (CREV) Stock Down Today?
↗
December 06, 2023
Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call.
Via
InvestorPlace
Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?
↗
December 06, 2023
ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA.
Via
InvestorPlace
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
↗
December 06, 2023
Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.
Via
Benzinga
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
↗
December 06, 2023
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
December 06, 2023
It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning!
Via
InvestorPlace
ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
↗
November 20, 2023
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand®, has launched an advanced Retrieval Augmented...
Via
Benzinga
EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval
↗
November 13, 2023
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary BioStrand has published a preprint of its white paper titled "New Paradigm for Biological Sequence Retrieval Inspired by Natural
Via
Benzinga
Overcoming The Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
↗
October 19, 2023
Biotechnology research involves a vast amount of complex information that spans different dimensions, such as the functions of proteins, the 3D structures of molecules and the genetic information...
Via
Benzinga
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
↗
October 12, 2023
The introduction of artificial intelligence (AI) in healthcare has revolutionized the field, allowing for a more personalized approach to patient care. AI algorithms have the ability to process and...
Via
Benzinga
Topics
Artificial Intelligence
Earnings Scheduled For July 7, 2023
↗
July 07, 2023
Companies Reporting Before The Bell • ImmunoPrecise Antibodies (NASDAQ:IPA) is expected to report quarterly loss at $0.13 per share on revenue of $4.31 million.
Via
Benzinga
Costco, AZZ And 3 Stocks To Watch Heading Into Friday
↗
July 07, 2023
With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Sentiment Drops Following Economic Reports
↗
July 07, 2023
The CNN Money Fear and Greed index showed some a decline in overall sentiment among U.S. investors on Thursday. The Dow Jones dropped more than 300 points on Thursday as investors assessed the recent...
Via
Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
March 21, 2023
On Tuesday, 74 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.